Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin a phase I-II study (original ) (raw )Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer
Eduardo Rosenblatt
Oral Oncology, 1997
View PDFchevron_right
Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer
John Jacobs
American Journal of Surgery, 1984
View PDFchevron_right
Induction Chemotherapy (Cisplatin + 5-Fluorouracil) and Radiotherapy in Advanced Squamous Cell Carcinoma of the Head and Neck
Anders Biörklund
Acta Oncologica, 1991
View PDFchevron_right
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5‐fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck
M. Biglietto , Giacomo Carteni
Cancer, 1999
View PDFchevron_right
Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck
Lance Heilbrun
Head & Neck, 2007
View PDFchevron_right
Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5FU infusion and cisplatin
John Jacobs
Cancer, 1985
View PDFchevron_right
Docetaxel, Cisplatin, Leucovorin and 5- Fluorouracil versus Leucovorin, 5-Fluorouracil, and Cisplatin as Neoadjuvant Chemotherapy Followed by Chemoradiation in Head and Neck Cancer
Akramul Islam
SAS journal of medicine, 2023
View PDFchevron_right
Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan
Naomi Kiyota
Japanese Journal of Clinical Oncology, 2009
View PDFchevron_right
Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer
Muhyi Al-Sarraf
The American Journal of Surgery, 1982
View PDFchevron_right
Induction chemotherapy with docetaxel, cisplatin, fluorouracil and l-leucovorin for locally advanced head and neck cancers: a modified regimen for Japanese patients
Andrea Berghold
Anti-Cancer Drugs, 2003
View PDFchevron_right
Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck
Maurice Schneider
British Journal of Cancer, 1986
View PDFchevron_right
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Ricard Mesía
New England Journal of Medicine, 2007
View PDFchevron_right
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study
Antonio Rueda Lara
European Journal of Cancer, 2005
View PDFchevron_right
Radiochemotherapy Including Cisplatin Alone versus Cisplatin + 5Fluorouracil for Locally Advanced Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck
George Hakim
Strahlentherapie Und Onkologie, 2009
View PDFchevron_right
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Roy Vera
New England Journal of Medicine, 2007
View PDFchevron_right
Concomitant chemo/radiotherapy for advanced carcinoma of the head and neck
Patrick Bradley
British Journal of Radiology, 1991
View PDFchevron_right
Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer
Kailash Narayan
European Journal of Cancer, 1996
View PDFchevron_right
Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (MO) disease
Esteban Cvitkovic
Cancer, 1991
View PDFchevron_right
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study
Joseph Kerger , Carl Van Laer
Annals of Oncology, 2004
View PDFchevron_right
Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up
Barbara Burtness
Journal of Clinical Oncology, 2004
View PDFchevron_right
A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas
M. Amin Mosleh-Shirazi
Iranian Red Crescent Medical Journal, 2011
View PDFchevron_right
Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C
S. Chapet
European Journal of Cancer, 1996
View PDFchevron_right
Response Rate and Toxicity of Docetaxel / Cisplatin /5FU in Comparison with Cisplatin / 5FU Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
ahmad ameri
2013
View PDFchevron_right
Induction chemotherapy in head and neck cancer
Laval Grimard
Annals of Oncology, 2006
View PDFchevron_right